Question 1

What is the catalog number for CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human) is 16108121.

Question 2

What sizes are available for CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

CHRDL1 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

PMEPA1 / TMEPAI (Tumor Suppressor Oncoprotein) (PMEPA1/2697), CF647 conjugate, 0.1mg/mL

CD43 (T-Cell Marker) (rSPN/1094), Biotin conjugate, 0.1mg/mL

Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF405S conjugate, 0.1mg/mL

Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker) (rCALD1/820), CF568 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/1952), 1mg/mL